To further explore the resistance mechanism of anti-CSF-1R therapy in GBM, we applied translatome profiling in a highly refractory G422TN-GBM mouse model, which accurately replicates the therapeutic responses and tumor recurrence of human GBM [21–26]. Here, CSF1R is linked to neoplasm.